|
Antigen
|
Age group (years)
|
Site
|
No of participants
|
Median age (IQR)
|
Median OD (IQR)
|
p value
|
|---|
|
Walukuba vs Kihihi
|
Walukuba vs Nagongera
|
Kihihi vs Nagongera
|
|---|
|
MSP1-19
|
1–4
|
Walukuba
|
12
|
3 (2–4)
|
0.71 (0.60–1.10)
|
0.08
|
0.041
|
0.44
|
|
Kihihi
|
18
|
3 (1–4)
|
0.90 (0.70–1.17)
|
|
Nagongera
|
24
|
1 (1–3)
|
1.00 (0.73–1.29)
|
|
5–15
|
Walukuba
|
16
|
12 (6–13)
|
0.80 (0.65–1.25)
|
0.5
|
0.4
|
0.8
|
|
Kihihi
|
76
|
12 (8–13)
|
0.89 (0.63–1.12)
|
|
Nagongera
|
74
|
11 (7–13)
|
0.87 (0.63–1.17)
|
|
>15
|
Walukuba
|
64
|
28 (20–40)
|
0.82 (0.61–1.1)
|
0.029
|
0.011
|
0.4
|
|
Kihihi
|
181
|
35 (25–48)
|
0.97 (0.70–1.27)
|
|
Nagongera
|
116
|
39 (25–55)
|
1.00 (0.67–1.30)
|
|
Total
| | |
581
|
|
AMA-1
|
1–4
|
Walukuba
|
18
|
2 (1–3)
|
0.86 (0.59–1.10)
|
0.95
|
0.18
|
0.19
|
|
Kihihi
|
21
|
3 (2–4)
|
0.79 (0.65–1.11)
|
|
Nagongera
|
63
|
3 (2–4)
|
0.92 (0.67–1.2)
|
|
5–15
|
Walukuba
|
76
|
9 (6–12)
|
0.92 (0.67–1.07)
|
0.005
|
0.0001
|
0.6
|
|
Kihihi
|
125
|
11 (8–13)
|
1.1 (0.80–1.15)
|
|
Nagongera
|
251
|
9 (7–12)
|
1.1 (0.85–1.2)
|
|
>15
|
Walukuba
|
89
|
27 (22–32)
|
0.72 (0.61–0.88)
|
0.0001
|
0.0007
|
0.62
|
|
Kihihi
|
197
|
34 (22–47)
|
0.85 (0.68–1.1)
|
|
Nagongera
|
189
|
34 (22–50)
|
0.87 (0.65–1.1)
|
|
Total
| | |
1029
|
- Statistically significant values (p < 0.05) are in italics
